Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat cancers. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.


CSE:BUX - Post by User

Post by geodcanon Dec 10, 2020 1:37am
181 Views
Post# 32074663

syncing up with Questrade

syncing up with Questradeprobably can't hurt.  I like our concept but don't feel overly confident in our management who I think are dedicated doctors and scientists and not very promotional or firecracker types that can generate some excitement.  Questrade has a following and with a little of that type of promotional ability that they bring to the table could get some new blood and tell our story.  Biomark dangled that teaser out about Covid detection which is sort of in our wheelhouse and let it go cold.  I'm pretty sure Questrade or somebody similar would have run that for all it is worth.  Coming up with an invention that is a hot ticket item and needed could have increased the marketcap with some promotion behind it and even put some money in the bank account to finance such an item.  glta and dyodd
<< Previous
Bullboard Posts
Next >>